News

Barcode medication administration (BCMA) is one of the most effective tools hospitals have for reducing medication errors, but failures happen more often than they should. Those failures come in two forms: barcodes that can’t be scanned due to packaging or print quality issues, and barcodes that scan successfully but contain incorrect data due to manual entry errors. Both problems start upstream, in how medications are packaged, labeled, and entered into the system before they ever reach the bedside.

The Short Answer: Automated syringe labeling outperforms hand labeling in accuracy, consistency, and long-term cost for facilities handling moderate to high volumes. Manual labeling works for small-scale needs, but automation significantly reduces medication errors, supports regulatory compliance, and delivers better patient safety outcomes across the board.

The global pharmaceutical packaging market size continues to expand, driven by increasing demand for pharmaceutical products that prioritize accuracy, compliance, and patient-centered delivery.

Many pharmaceutical packaging costs don’t show up on the purchase order. They show up later as labor hours, wasted materials, rework, and compliance delays that become permanent line items. The decisions you make before installation day determine whether your operation runs lean or bleeds money quietly for years.

Drug shortages disrupt patient care by forcing last-minute substitutions, increasing medication errors, and adding hours of manual work to pharmacy operations. The best defense is a repeatable response process that covers early detection, standardized substitutions, clean inventory, and reliable packaging and barcode controls.

In today’s fast-paced healthcare environment, operational efficiency isn’t just a nice-to-have. It’s essential for delivering quality patient care. For one community hospital in the Northeastern United States, the journey toward better hospital automation began with a simple realization: their medication packaging process was holding them back, and MPI was their solution.

Smart capital decisions in healthcare—particularly in medication packaging and pharmacy operations—directly improve return on investment, patient safety, and staff retention by reducing manual work, minimizing errors, and freeing clinical teams to focus on patient care rather than repetitive administrative tasks.

The financial impact extends from manufacturers importing raw materials to hospitals purchasing finished medications. For healthcare facilities, pharmacies, and pharmaceutical manufacturers, these tariffs translate to higher procurement costs, supply chain disruptions, and difficult decisions about sourcing strategies.

The financial impact extends from manufacturers importing raw materials to hospitals purchasing finished medications. For healthcare facilities, pharmacies, and pharmaceutical manufacturers, these tariffs translate to higher procurement costs, supply chain disruptions, and difficult decisions about sourcing strategies.